Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis

Microbial Pathogenesis

Volumn 38, Issue 1, 2005, Pages 13-21

  Keadle, Tammie L ^a   Stuart, Patrick M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed type hypersensitivity (DTH); Herpetic stromal keratitis; Interleukin 10 (IL 10)

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; RECOMBINANT INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA OPACITY; DELAYED HYPERSENSITIVITY; HERPES SIMPLEX KERATITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; ULTRAVIOLET B RADIATION;

ANIMALS; CORNEA; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-10; KERATITIS, HERPETIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECURRENCE; ULTRAVIOLET RAYS; VIRUS ACTIVATION;

EID: 11844256360     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2004.09.003     Document Type: Article

References (38)

1. J.W. Streilein, M.R. Dana, and B.R. Ksander Immunity causing blindness: five different paths to herpes stromal keratitis Immunol Today 18 1997 443 449
2. M.G. Niemialtowski, and B.T. Rouse Predominance of Th1 cells in ocular tissue during herpetic stromal keratitis J Immunol 149 1992 3035 3041
3. R.L. Hendricks, T.M. Tumpey, and A. Finnegan IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1 infected mice J Immunol 149 1992 3023 3038
4. C.K. Newell, S. Martin, D. Sendele, C.M. Mercadal, and B.T. Rouse Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology J Virol 63 1989 769 781
5. M.Z. Doymaz, and B.T. Rouse Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes Invest Ophthalmol Vis Sci 33 1992 2165 2178
6. J.S. Babu, S. Kanangat, and B.T. Rouse T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis J Immunol 154 1995 4822 4829
7. R.N. Lausch, W.R. Kleinschrodt, C. Monteiro, S.G. Kayes, and J.E. Oakes Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity Invest Ophthalmol Vis Sci 26 1985 1509 1515
8. B.R. Ksander, and R.L. Hendricks Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions Invest Ophthalmol Vis Sci 28 1987 1986 1993
9. A.A. Nash, P.G. Gell, and P. Wildy Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity Immunology 43 1981 153 159
10. K. Asadullah, W. Sterry, and H.D. Volk Interleukin-10 therapy - review of a new approach Pharm Rev 55 2003 241 269
11. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin 10 receptor W.E. Paul Annual review of immunology 2001 Annual reviews Palo Alto 683 765
12. N. Cole, M. Krockenberger, F. Stapleton, S. Khan, E. Hume, and A.J. Husband Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice Inf Immun 71 2003 1328 1336
13. M.L. Garcia-Hernandez, R. Hernandez-Pando, P. Gariglio, and J. Berumen Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation Immunology 105 2002 231 243
14. J.S. Silvestre, Z. Mallat, M. Duriez, R. Tamarat, M.F. Bureau, and D. Scherman Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb Circ Res 87 2000 448 452
15. L. Romani, A. Mancacci, E. Cenci, G.D. Sero, F. Bistoni, and P. Puccetti An immunoregulatory role for neutrophis in CD4+ T helper subset selection in mice with candidiasis J Immunol 158 1997 2356 2362
16. X.T. Yan, Z. minsheng, J.E. Oakes, and R.N. Lausch Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea J Leukoc Biol 69 2001 149 157
17. M. Daheshia, N. Kuklin, E. Manickan, S. Chun, and B.T. Rouse Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines Vaccine 16 1998 1103 1110
18. M. Daheshia, N. Kuklin, Kanangat, E. Manickan, and B.T. Rouse Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10 J Immunol 159 1997 1945 1952
19. S. Chun, M. Daheshia, N.A. Kuklin, and B.T. Rouse Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes J Virol 72 1998 5545 5551
20. T.M. Tumpey, V.M. Elner, S. Chen, J.E. Oakes, and R.N. Lausch Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1 J Immunol 153 1994 2258 2264
21. T.M. Tumpey, H. Cheng, X. Yan, J.E. Oakes, and R.N. Lausch Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10 J Leukoc Biol 63 1998 486 492
22. K.A. Laycock, S.F. Lee, R.H. Brady, and J.S. Pepose Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet b radiation Invest Ophthalmol Vis Sci 32 1991 2741 2748
23. J.S. Pepose, D.A. Leib, P.M. Stuart, and E.L. Easty Herpes simplex virus: anterior segment of the eye J. Pepose G.N. Holland K.R. Wilhelmus Ocular infection and immune 1996 Mosby St Louis 905 932
24. J.K. Miller, K.A. Laycock, J.A. Umphress, K.K. Hook, P.M. Stuart, and J.S. Pepose A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice Cornea 15 1996 497 504
25. T.L. Keadle, N. Usui, K.A. Laycock, Y. Kumano, J.S. Pepose, and P.M. Stuart Cytokine expression in murine corneas during recurrent herpetic stromal keratitis Occ Immunol Inflamm 9 2001 193 205
26. J.H. Chace, J.S. Cowdery, and E.H. Field Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naïve CD4 cells and spares activated CD4 cells J Immunol 152 1994 405 412
27. C.M. Weyand, J. Goronzy, K. Swarztrauber, and C.G. Fathman Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responses Transplant 47 1989 1034 1038
28. C.S. Foster, Y. Tsai, J.G. Monroe, R. Campbell, M. Cestari, and R. Wetzig Genetic studies on murine susceptibility to herpes simplex keratitis Clin Immunol Immunopathol 40 1986 313 325
29. C. Lopez Genetics of natural resistance to herpesvirus infections in mice Nature 258 1975 152 153
30. T.L. Keadle, J.L. Morris, J.S. Pepose, and P.M. Stuart CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice Microbial Path 32 2002 255 262
31. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10 deficient mice develop chronic enterocolitis Cell 75 1993 263 274
32. T.H. Stumpf, C. Shimeld, D.L. Easty, and T.J. Hill Cytokine production in a murine model of recurrent herpetic stromal keratitis Invest Ophthalmol Vis Sci 42 2001 372 378
33. C. Shimeld, D.L. Easty, and T.J. Hill Reactivation of herpes simplex virus type 1 in mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines J Virol 73 1999 1767 1773
34. C. Shimeld, J.L. Whiteland, N.A. Williams, D.L. Easty, and T.J. Hill Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1 J Gen Virol 78 1997 3317 3325
35. H. Minagawa, K. Hashimoto, and Y. Yanagi Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections J Gen Virol 85 2004 343 347
36. T. Liu, K.M. Khanna, B.N. Carriere, and R.L. Hendricks Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons J Virol 75 2001 11178 11184
37. M. Minami, M. Kita, X.O. Yan, K.K. Hook, E.D. Fenoglio, and M. Francotte Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection J Interferon Cyto Res 22 2002 671 676
38. T.L. Keadle, K.A. Laycock, and J.K. Miller Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice J Infect Dis 176 1997 331 338